Skip to main content
Top
Published in: Angiogenesis 3/2002

01-09-2002

Neovascularization and vascular markers in a foreign body reaction to subcutaneously implanted degradable biomaterial in mice

Authors: Machteld J. van Amerongen, Grietje Molema, Josée Plantinga, Henk Moorlag, Marja J.A. van Luyn

Published in: Angiogenesis | Issue 3/2002

Login to get access
Metadata
Title
Neovascularization and vascular markers in a foreign body reaction to subcutaneously implanted degradable biomaterial in mice
Authors
Machteld J. van Amerongen
Grietje Molema
Josée Plantinga
Henk Moorlag
Marja J.A. van Luyn
Publication date
01-09-2002
Publisher
Kluwer Academic Publishers
Published in
Angiogenesis / Issue 3/2002
Print ISSN: 0969-6970
Electronic ISSN: 1573-7209
DOI
https://doi.org/10.1023/A:1023822504224

Other articles of this Issue 3/2002

Angiogenesis 3/2002 Go to the issue

Instructions for Authors

Instructions for authors

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine